B. Tümmler

745 total citations
19 papers, 505 citations indexed

About

B. Tümmler is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Molecular Medicine. According to data from OpenAlex, B. Tümmler has authored 19 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Molecular Medicine. Recurrent topics in B. Tümmler's work include Cystic Fibrosis Research Advances (15 papers), Neonatal Respiratory Health Research (7 papers) and Bacterial biofilms and quorum sensing (4 papers). B. Tümmler is often cited by papers focused on Cystic Fibrosis Research Advances (15 papers), Neonatal Respiratory Health Research (7 papers) and Bacterial biofilms and quorum sensing (4 papers). B. Tümmler collaborates with scholars based in Germany, Belgium and France. B. Tümmler's co-authors include Ute Römling, H. von der Hardt, Manfred Ballmann, Jorge Lalucat, Stefanie Breitenstein, T Brandt, Nico Derichs, Thomas von Känel, Antonia Zapf and Javier Sanz and has published in prestigious journals such as European Respiratory Journal, Thorax and Journal of Medical Genetics.

In The Last Decade

B. Tümmler

18 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Tümmler Germany 10 310 182 66 50 47 19 505
H. Barr United Kingdom 10 204 0.7× 225 1.2× 34 0.5× 94 1.9× 20 0.4× 25 430
A. Christopher Boyd United Kingdom 11 234 0.8× 231 1.3× 106 1.6× 14 0.3× 30 0.6× 21 509
Anna Tai Australia 11 98 0.3× 134 0.7× 18 0.3× 75 1.5× 58 1.2× 30 307
A Scharfman France 12 154 0.5× 202 1.1× 37 0.6× 8 0.2× 18 0.4× 26 402
Anu Surendra Canada 5 201 0.6× 296 1.6× 24 0.4× 22 0.4× 7 0.1× 6 522
E. Amelina Russia 10 213 0.7× 93 0.5× 26 0.4× 14 0.3× 9 0.2× 77 321
R C Stern United States 8 213 0.7× 151 0.8× 44 0.7× 67 1.3× 5 0.1× 12 381
N C Munro United Kingdom 7 236 0.8× 103 0.6× 67 1.0× 21 0.4× 6 0.1× 9 404
Rainer Fislage Germany 9 117 0.4× 122 0.7× 44 0.7× 9 0.2× 30 0.6× 14 312
Giovanna Pizzamiglio Italy 8 135 0.4× 87 0.5× 11 0.2× 45 0.9× 12 0.3× 16 270

Countries citing papers authored by B. Tümmler

Since Specialization
Citations

This map shows the geographic impact of B. Tümmler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Tümmler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Tümmler more than expected).

Fields of papers citing papers by B. Tümmler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Tümmler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Tümmler. The network helps show where B. Tümmler may publish in the future.

Co-authorship network of co-authors of B. Tümmler

This figure shows the co-authorship network connecting the top 25 collaborators of B. Tümmler. A scholar is included among the top collaborators of B. Tümmler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Tümmler. B. Tümmler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Stahl, Matthias, Isabell Ricklefs, Christian Dopfer, et al.. (2018). WS14.3 Randomised, double-blind, controlled pilot study on safety and efficacy of hypertonic saline as preventive inhalation therapy in infants with CF (PRESIS). Journal of Cystic Fibrosis. 17. S25–S26. 3 indexed citations
2.
Tümmler, B.. (2016). Therapie der Mukoviszidose mit CFTR-Modulatoren. Pneumologie. 70(5). 301–313. 5 indexed citations
3.
Losada, Patricia Morán, Ian A. Yang, Philippe Chouvarine, et al.. (2016). WS07.1 Comparison of T-RFLP, 16S rDNA sequencing and metagenomics of respiratory microbiota in patients with cystic fibrosis. Journal of Cystic Fibrosis. 15. S11–S11. 1 indexed citations
4.
Cramer, Nina, Sebastian Fischer, Patricia Morán Losada, et al.. (2014). 54 Intraclonal genome diversity of the major Pseudomonas aeruginosa clones C and PA14. Journal of Cystic Fibrosis. 13. S60–S60. 1 indexed citations
5.
Fuchs, Susanne, Helmut Ellemunter, Uwe Mellies, et al.. (2011). Multicentre feasibility and variability of measuring the lung clearance index in healthy volunteers. European Respiratory Journal. 38(Suppl 55). 3221–3221. 1 indexed citations
6.
Munder, Antje, Florian Wölbeling, Urs Baumann, Erich Gulbins, & B. Tümmler. (2011). 58 Route of application plays a distinct role for the outcome of a Pseudomonas aeruginosa airway infection in cystic fibrosis mouse models. Journal of Cystic Fibrosis. 10. S15–S15. 1 indexed citations
7.
Cramer, Nina, Jens Klockgether, Colin Davenport, & B. Tümmler. (2011). 152* Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Journal of Cystic Fibrosis. 10. S38–S38. 4 indexed citations
8.
Stanke, Frauke, Tim Becker, Vinod Kumar, et al.. (2010). Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. Journal of Medical Genetics. 48(1). 24–31. 55 indexed citations
9.
Derichs, Nico, Javier Sanz, Thomas von Känel, et al.. (2010). Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data. Thorax. 65(7). 594–599. 105 indexed citations
10.
Mainz, Jochen G., B. Wiedemann, W. Pfister, et al.. (2009). Dynamics of upper and lower airway colonisation with P.aeruginosa and S.aureus in CF-patients within 3.5 years. Journal of Cystic Fibrosis. 8. S64–S64.
11.
Bragonzi, Alessandra, Moira Paroni, Sara Montanari, et al.. (2008). PSEUDOMONAS AERUGINOSA PATHOGENICITY WITHIN CLONAL STRAINS FROM PATIENTS WITH CYSTIC FIBROSIS. Journal of Cystic Fibrosis. 7. S17–S17. 1 indexed citations
12.
Häußler, Susanne, Christine Lehmann, Manfred Rohde, et al.. (2003). Fatal Outcome of Lung Transplantation in Cystic Fibrosis Patients due to Small-Colony Variants of the Burkholderia cepacia Complex. European Journal of Clinical Microbiology & Infectious Diseases. 22(4). 249–253. 51 indexed citations
13.
Bronsveld, Inez, Jan Bijman, Frauke Mekus, et al.. (1999). Clinical presentation of exclusive cystic fibrosis lung disease. Thorax. 54(3). 278–281. 12 indexed citations
14.
Lalucat, Jorge, et al.. (1997). Genome Organization of Pseudomonas stutzeri and Resulting Taxonomic and Evolutionary Considerations. International Journal of Systematic Bacteriology. 47(1). 132–143. 70 indexed citations
15.
Bernhard, Wolfgang, Jiu‐Yao Wang, Thomas Tschernig, et al.. (1997). Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice. Thorax. 52(8). 723–730. 23 indexed citations
16.
Tümmler, B., Stefanie Breitenstein, Igor Dias Brockhausen, et al.. (1997). Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.. PubMed. 249–55. 47 indexed citations
17.
Brandt, T, Stefanie Breitenstein, H. von der Hardt, & B. Tümmler. (1995). DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.. Thorax. 50(8). 880–882. 59 indexed citations
18.
Brézillon, Stéphane, Florence Dupuit, Jocelyne Hinnrasky, et al.. (1995). Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients.. PubMed. 72(2). 191–200. 56 indexed citations
19.
Tümmler, B.. (1987). Unusual mechanism of pathogenicity of pseudomonas aeruginosa isolates from patients with cystic fibrosis. Infection. 15(4). 311–312. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Barr Breakdown of academic impact, for papers by A. Christopher Boyd Breakdown of academic impact, for papers by Anna Tai Breakdown of academic impact, for papers by A Scharfman Breakdown of academic impact, for papers by Anu Surendra Breakdown of academic impact, for papers by E. Amelina Breakdown of academic impact, for papers by R C Stern Breakdown of academic impact, for papers by N C Munro Breakdown of academic impact, for papers by Rainer Fislage Breakdown of academic impact, for papers by Giovanna Pizzamiglio
Rankless by CCL
2026